Annual Report 1998-99

傑出研究•Outstanding Research 醫學院‧Faculty of Medicine 肝癌新療法 Ne w Treatmen t fo rLive r Cance r 腫瘤學系與外科學系開發了兩項肝癌新療法。一是採用碘放射同位素藥物，以降低切除腫瘤後 的復發率。二是全新的「化療及免疫治療」方法，可把原來不能以手術切除的腫瘤變為可切 除；這些化療後切除下來的腫瘤經化驗證實組織早已壞死，顯示新療法有效。 New treatment methods for hepatocellular carcinoma were developed by the Department of Clinical Oncology and the Department of Surgery. Studies show that the administration of an agent carrying a radioactive isotope of iodine can significantly reduce the risk of recurrence after the surgical removal of the tumour. A new systemic chemotherapeutic regimen known as chemoimmunotherapy may also turn ‘inoperable’ tumours int o operable ones. Surgically removed tumours after chemotherapy are often found to be completely necrotic, indicating that the treatment has caused a complete pathological remission.